This inventor holds 3 USPTO granted patents. Top assignee: The State University of New York. Active years: 1984-1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Buffalo, NY (US) (1984)
- Silver Spring, MD (US) (1988)
- Silver Springs, MD (US) (1990)
Company Filing History:
Years Active: 1984-1990
Title: Alan C. Schroeder: Innovator in Antiviral Research
Introduction: Alan C. Schroeder, an inventive mind based in Silver Springs, MD, has made significant contributions to the field of antiviral research. With a total of three patents, his work focuses on developing novel therapeutic agents that target viral infections, particularly those caused by herpes simplex virus type 2 (HSV-2).
Latest Patents: Alan's latest inventions include notable patents that showcase his expertise in synthesizing nucleosides with antiviral properties. One of his recent patents, "5-ioso-2-pyrimidinone nucleoside," describes a compound with remarkable antiviral activity and low toxicity to host cells, positioning it as an effective treatment for HSV-2. Another significant patent, "Novel 5-substituted 2-pyrimidinone nucleosides and methods of use," outlines compounds that inhibit the replication of DNA viruses through the induction of thymidine kinase enzyme formation, demonstrating a range of potential applications in antiviral therapy.
Career Highlights: Alan C. Schroeder holds a prominent position at the Research Foundation of the State University of New York, where he has dedicated his research efforts to finding innovative solutions to combat viral diseases. His work has contributed to advancing the understanding of nucleoside chemistry and its applications in medicine.
Collaborations: Throughout his career, Alan has collaborated with esteemed colleagues, including Thomas J. Bardos and Yung-Chi Cheng. These collaborations have furthered research initiatives aimed at developing effective antiviral therapies and expanding the knowledge base surrounding viral infections.
Conclusion: Alan C. Schroeder's work exemplifies the spirit of innovation in the field of antiviral research. With his patents paving the way for new therapeutic strategies, his contributions hold promise for significant advancements in the treatment of viral diseases. As he continues to explore the potential of nucleosides, the impact of his work on public health remains a vital area of interest.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile